MELLO Sarita V. (US),МЕЛЛО Сарита В. (US),ARVANITIDOU Ehvanzhelia (US),АРВАНИТИДОУ Эванжелиа (US),MELLO SARITA V.,МЕЛЛО Сарита В.,ARVANITIDOU EHVANZHELIA,АРВАНИТИДОУ Эванжелиа
申请号：
RU2013102892/15
公开号：
RU0002535088C2
申请日:
2010.06.23
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions relates to the field of preparations for the oral cavity care and methods of their application. The composition for the oral cavity care contains from 0.6 wt % to 1 wt % of arginine in a D- or L-form or in the form of salt with lauroylsulphuric acid, at least one mucoadhesive polymer, at least one pyrophosphate compound and, at least one component, selected from the group, consisting of zinc salts, potassium salts, strontium salts and their mixtures. The method of realising one or more of the effects, selected from the group, consisting of the reduction of the teeth hypersensitivity； reduction or inhibition of dental caries formation； reduction or inhibition of demineralisation and contribution to the teeth remineralisation； reduction or inhibition of gingivitis； inhibition of a microbial biofilm formation in the oral cavity； reduction of dental plaque accumulation； treatment of the mouth dryness； reduction of the teeth erosion； protection of enamel after an erosive impact； and cleaning and/or whitening teeth and cleaning the oral cavity, includes the application of the said composition in the oral cavity. The product consists of a packing material and the claimed composition, with the packing material containing a label, which indicates that the oral composition is effective with respect to the reduction or prevention of dentin hypersensitivity.EFFECT: group of inventions provides successful realisation of an internal blockage of dentinal canals, simultaneously providing the antibacterial and/or anti-caries efficiency.19 cl, 4 tbl, 2 exГруппа изобретений относится к области средств для ухода за полостью рта и способам их применения. Композиция для ухода за полостью рта содержит от 0,6% до 1% по массе аргинина в D- или L-форме или в виде соли с лауроилсерной кислотой, по меньшей мере, один мукоадгезивный полимер, по меньшей мере, одно соединение пирофосфата и, по меньшей мере, один компонент, выбранный
